Slide 1: Q2 2025 Earnings Call
Q2 2025 Earnings Call July 31, 2025
Slide 2: Cautionary Statements
Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe
Slide 3: Puneet Khanna, President and Chief Executive Officer
PUNEET KHANNA PRESIDENT AND CHIEF EXECUTIVE OFFICER 3
Slide 4: Q2 2025 Highlights
Q2 2025 Highlights • Revenue of $91.4 million • Adjusted EBITDA1 of $8.0 million • Net income of $0.6 million • Ending bed count of 91,062 4 1. Adjusted EBITDA is a non-IFRS financial measure. See “Non-IFRS Financial Measures and Other Financial Measures” for further information.
Slide 5: Suzanne Brand, Chief Financial Officer
SUZANNE BRAND CHIEF FINANCIAL OFFICER 5
Slide 6: Financial Results | Revenue
Q2 2025 Financial Results | Revenue • 90,048 Average Beds Serviced1 in Q2 2025: -0.7% vs Q2 2024 and +2.7% vs Q1 2025 • Revenue increased quarter-over-quarter primarily due to an increase in the average number of beds serviced 6 1. Average Beds Serviced is a supplementary financial measure. See “Non
Slide 7: Financial Results | Adjusted EBITDA
Q2 2025 Financial Results | Adjusted EBITDA • Adjusted EBITDA1 increased primarily due to certain efficiencies and cost savings initiatives • Adjusted EBITDA margin1 increased 60 basis points year-over-year to 8.8% and increased 10 basis points quarter-over- quarter 7 1. Adjusted EBITDA and Adjusted
Slide 8: Financial Results | Net Income
Q2 2025 Financial Results | Net Income • Elimination of net loss driven primarily by a non-cash adjustment related to an intangible asset impairment recorded during Q2 2024 due to the sale of a non- core pharmacy location; and decreases in finance costs, depreciation and amortization expenses; parti
Slide 9: Balance Sheet
Balance Sheet As at June 30, 2025 • Quarter-over-quarter decrease in cash balance and increase in Net Debt due to retirement of vendor take-back loan and timing of certain working capital items 9 1. Net Debt is a non-IFRS financial measure and Net Debt to Adjusted EBITDA is a non-IFRS ratio. See “No
Slide 10: Puneet Khanna, President and Chief Executive Officer
PUNEET KHANNA PRESIDENT AND CHIEF EXECUTIVE OFFICER 10
Slide 11: Organizational Excellence
Organizational Excellence Realigned our executive leadership team to support our strategic priorities: • Adrianne Sullivan-Campeau - Chief Employee and Customer Experience Officer • Travis Featherstone - Chief Clinical Officer • Alpinder Grewal - Chief Operating Officer • Erwin Van Hout - Senior Vic
Slide 12: Growth
Growth • New beds onboarded in Q2 will have full revenue contribution in Q3 • Robust sales pipeline • Large national and regional customers continue to build new homes and acquire smaller competitors 12
Slide 13: Slide 13